| abstract |
The variable heavy chain comprises the CDR sequences CDR1, CDR2, and CDR3, and CDR1 is selected from the group consisting of SEQ ID NOs: 9, 10, 11, 12, and CDR2 consists of SEQ ID NOs: 13, 14, 15 Selected from the group, and CDR3 is selected from the group consisting of SEQ ID NO: 16, 17, wherein the CDRs are selected independently of each other or in a chimeric, humanized variant, or antibody fragment An antibody that binds to human CCR5 comprising a variable heavy chain or variable light chain, characterized in that it has advantageous properties for the treatment of immunosuppressive diseases. |